October 10th, 2013
Isaac Whitman and Steven Kawut discuss their study of the sensitivity and specificity of electrocardiographic criteria in screening for MRI-detected right ventricular hypertrophy in patients without clinical cardiovascular disease.
December 8th, 2012
Thoughts from Dr. Wes about the strengths and limitations of AliveCor’s ECG Case for iPhone, newly approved by the FDA
July 30th, 2012
The U.S. Preventive Services Task Force (USPSTF) has reaffirmed its 2004 recommendation against ECG screening for asymptomatic adults who are already at low risk for coronary heart disease (CHD). The task force also concluded that there was insufficient evidence to assess the risks and benefits of ECG screening in asymptomatic people at intermediate or high risk for […]
May 3rd, 2012
The New York Times’ “abysmal” report on screening young athletes for heart risk prompts Wes Fisher to envision how such a misguided recommendation could affect athletes and their families.